Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.

MLA

Welsh, J. L., et al. “Pharmacological Ascorbate with Gemcitabine for the Control of Metastatic and Node-Positive Pancreatic Cancer (PACMAN): Results from a Phase I Clinical Trial.” Cancer Chemotherapy and Pharmacology, vol. 71, no. 3, Mar. 2013, pp. 765–75. EBSCOhost, https://doi.org/10.1007/s00280-013-2070-8.

APA

Welsh, J. L., Wagner, B. A., van’t Erve, T. J., Zehr, P. S., Berg, D. J., Halfdanarson, T. R., Yee, N. S., Bodeker, K. L., Du, J., Roberts, L. J., 2nd, Drisko, J., Levine, M., Buettner, G. R., & Cullen, J. J. (2013). Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemotherapy and Pharmacology, 71(3), 765–775. https://doi.org/10.1007/s00280-013-2070-8

Chicago

Welsh, J L, B A Wagner, T J van’t Erve, P S Zehr, D J Berg, T R Halfdanarson, N S Yee, et al. 2013. “Pharmacological Ascorbate with Gemcitabine for the Control of Metastatic and Node-Positive Pancreatic Cancer (PACMAN): Results from a Phase I Clinical Trial.” Cancer Chemotherapy and Pharmacology 71 (3): 765–75. doi:10.1007/s00280-013-2070-8.